Tim Kutzkey, Ph.D.

Chief Executive Officer
Managing Partner, The Column Group

Dr. Tim Kutzkey serves as acting Chief Executive Officer at Surrozen. He is a Managing Partner at The Column Group, is Chairman at Nurix and serves on the Board of Directors for Carmot Therapeutics, Neurona Therapeutics and Kallyope.  Dr. Kutzkey has played an active role in the launch of nearly a dozen of The Column Group’s portfolio companies since joining the firm in 2007. His primary focus is company creation, often taking interim management roles at new start-ups until a permanent leadership team is recruited. In 2009 and 2010 he launched Nurix and Peloton Therapeutics, respectively, as the acting President and CEO. Dr. Kutzkey was formerly a scientist at KAI Pharmaceuticals, focused on the discovery and development of selective protein kinase C inhibitors. Prior to KAI, he completed his Ph.D. and postdoctoral training in the lab of Dr. Robert Tjian at UC Berkeley. Dr. Kutzkey completed his undergraduate education at Stanford University.